Gut-Mind Interactions in Psychedelic Healing: A Case Study Assessing the Effects of Huachuma and Ayahuasca on the Mind and Microbiome.

A 35-year-old woman with prior psychedelic experience took Ayahuasca and Huachuma (San Pedro cactus) in separate ceremonies. Both medicines sharply reduced her depression scores (Ayahuasca: from 18 to 6; Huachuma: from 12 to 2 on the Hamilton Depression Rating Scale) and increased her feelings of connectedness (Ayahuasca: from 62.3% to 95.37%; Huachuma: from 58.32% to 84.65% on the Watts Connectedness Scale). Stool samples showed that each medicine shifted the gut microbiome differently, but both reduced pro-inflammatory bacteria, normalized inflammation-linked species, and increased beneficial butyrate-producing bacteria. These microbial changes aligned with improved mood and reduced inflammation, suggesting that psychedelics may improve mental health partly through the microbiota-gut-brain axis.

Study at a glance

Abstract

Psychedelic plant medicines such as Ayahuasca and Huachuma (San Pedro cactus) are gaining scientific attention for their potential to improve mental health. However, the interplay between these traditional medicines, the gut microbiome, and mental health outcomes remains underexplored. The main objectives of this study are to investigate the effects of Ayahuasca and Huachuma ceremonies on the gut microbiome, depression, and subjective connectedness in a single patient and to generate hypotheses for future studies. A 35-year-old female with prior psychedelic experience participated in separate Ayahuasca and Huachuma ceremonies. Qualitative data were collected through patient interviews. Quantitative data included stool samples collected before and after each ceremony for microbiome analysis, as well as survey data using the Hamilton Depression Rating Scale (HAM-D) and Watts Connectedness Scale (WCS) administered pre- and post-ceremony. Both ceremonies resulted in substantial reductions in depression scores (HAM-D decreased: Ayahuasca from 18 to 6; Huachuma from 12 to 2) and connectedness scores (WCS increased: Ayahuasca from 62.3% to 95.37%; Huachuma from 58.32% to 84.65%). Although Ayahuasca and Huachuma induced different gut microbial composition shifts, reductions in pro-inflammatory taxa, normalization of inflammation-linked bacterial species, and increases in beneficial butyrate-producing bacterial species were observed for both. These microbial shifts aligned with improved subjective mental health and reduced inflammation. Qualitative interviews revealed distinct archetypal experiences with each medicine, informing personalized therapeutic approaches. This hypothesis-generating case study illustrates a potential link between psychedelic-induced microbiome changes and improvements in mental health which may contribute to reduced inflammation and sustained antidepressant effects via the microbiota-gut-brain axis.